Recent Updates
Recently added Catalysts
MDXG Positive Sentiment

MIMEDX to Host First Quarter 2026 Operating and Financial Results Conference Call on April 29

Key Takeaway: MiMedx Group, Inc. will announce its first quarter 2026 operating and financial results on April 29, 2026. The results will be shared in a conference call starting at 4:30 p.m. Eastern Time. Investors can access the call via a dedicated phone line or webcast, with a replay available for 30 days afterward.
Price reaction · baseline $3.2 (2026-04-21 close) · hit after-hours · clean, no other MDXG news in the window
day 0 close · peak
+3.4%

Market Sentiment Analysis

POSITIVE FACTORS

  • MIMEDX is reporting strong operational and financial results.
  • The company continues to innovate in the wound care sector.
  • Management is engaging with investors through a conference call.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~40 mo
Low dilution risk
Lead asset
Micronized DHACM
Phase 3 · Tendonitis;Achilles

Full Press Release Details

MARIETTA, Ga., April 22, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the first quarter ended March 31, 2026 after the market close on Wednesday, April 29, 2026. The MIMEDX senior management team will host a webcast and conference call to review its results beginning at 4:30 p.m. Eastern Time on the same day.
The conference call can be accessed using the following information:
Webcast:Click hereU.S. Investors: 877-407-6184International Investors: 201-389-0877Conference ID: 13759618
A replay of the webcast will be available for approximately 30 days on the Company’s website atwww.mimedx.comfollowing the conclusion of the event.
About MIMEDXMIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade and a half of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX provides a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. The Company’s vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life. For additional information, please visitwww.mimedx.com.

Contact:Matt NotarianniInvestor Relations470-304-7291mnotarianni@mimedx.com

Frequently Asked Questions

When will MIMEDX report its Q1 2026 results?

MIMEDX will report its Q1 2026 results on April 29, 2026.

What time is the MIMEDX conference call?

The conference call will begin at 4:30 p.m. Eastern Time.

How can investors access the conference call?

Investors can access the call via phone or webcast using provided details.

Is there a replay available for the conference call?

Yes, a replay will be available for approximately 30 days on MIMEDX's website.

Last updated: Apr 22, 2026